BETAMETHASONE

Betamethasone Adverse Events Reported to the FDA Over Time

How are Betamethasone adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Betamethasone, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Betamethasone is flagged as the suspect drug causing the adverse event.

Most Common Betamethasone Adverse Events Reported to the FDA

What are the most common Betamethasone adverse events reported to the FDA?

Drug Exposure During Pregnancy	144 (1.58%)
Condition Aggravated	106 (1.17%)
Drug Ineffective	97 (1.07%)
Pruritus	86 (.95%)
Erythema	85 (.93%)
Insomnia	76 (.84%)
Premature Baby	73 (.8%)
Dyspnoea	72 (.79%)
Pyrexia	69 (.76%)
Malaise	68 (.75%)
Caesarean Section	66 (.73%)
	Show More
Dizziness	61 (.67%)
Oedema Peripheral	57 (.63%)
Headache	56 (.62%)
Pain	53 (.58%)
Fall	52 (.57%)
Hypersensitivity	52 (.57%)
Loss Of Consciousness	52 (.57%)
Vomiting	47 (.52%)
Nausea	45 (.49%)
Rash	42 (.46%)
Syncope	42 (.46%)
Maternal Drugs Affecting Foetus	41 (.45%)
Anaphylactic Shock	40 (.44%)
Rash Pustular	39 (.43%)
Asthenia	38 (.42%)
Hypertension	38 (.42%)
Stevens-johnson Syndrome	38 (.42%)
Infection	37 (.41%)
Fatigue	36 (.4%)
Rash Pruritic	35 (.38%)
Diarrhoea	34 (.37%)
Pain In Extremity	34 (.37%)
Swelling	34 (.37%)
Toxic Anterior Segment Syndrome	33 (.36%)
Constipation	32 (.35%)
Convulsion	31 (.34%)
Injection Site Pain	31 (.34%)
Pleural Effusion	31 (.34%)
Urticaria	30 (.33%)
Drug Interaction	29 (.32%)
Eczema	29 (.32%)
Platelet Count Decreased	29 (.32%)
Pustular Psoriasis	29 (.32%)
Gait Disturbance	28 (.31%)
Sepsis	28 (.31%)
Cerebrovascular Accident	27 (.3%)
Acute Pulmonary Oedema	26 (.29%)
Alanine Aminotransferase Increased	26 (.29%)
Disseminated Intravascular Coagulat...	26 (.29%)
Hypoaesthesia	26 (.29%)
Hypokalaemia	26 (.29%)
Off Label Use	26 (.29%)
Tachycardia	26 (.29%)
Toxic Skin Eruption	26 (.29%)
Blood Glucose Increased	25 (.27%)
Eosinophilia	25 (.27%)
Respiratory Distress	25 (.27%)
Anxiety	24 (.26%)
Blood Pressure Decreased	24 (.26%)
C-reactive Protein Increased	24 (.26%)
Face Oedema	24 (.26%)
Feeling Abnormal	24 (.26%)
Flushing	24 (.26%)
Gastrointestinal Haemorrhage	24 (.26%)
Hyperglycaemia	24 (.26%)
Tremor	24 (.26%)
Arthralgia	23 (.25%)
Aspartate Aminotransferase Increase...	23 (.25%)
Blood Pressure Increased	23 (.25%)
Hepatic Function Abnormal	23 (.25%)
Rash Papular	23 (.25%)
Respiratory Failure	23 (.25%)
Anaemia	22 (.24%)
Feeling Hot	22 (.24%)
Glaucoma	22 (.24%)
Heart Rate Increased	22 (.24%)
Premature Labour	22 (.24%)
White Blood Cell Count Increased	22 (.24%)
Abdominal Pain	21 (.23%)
Adrenal Insufficiency	21 (.23%)
Blood Cholesterol Increased	21 (.23%)
Burning Sensation	21 (.23%)
Hypoxia	21 (.23%)
Renal Failure Acute	21 (.23%)
Back Pain	20 (.22%)
Chest Pain	20 (.22%)
Chills	20 (.22%)
Multi-organ Failure	20 (.22%)
Rash Erythematous	20 (.22%)
Abdominal Pain Upper	19 (.21%)
Abnormal Behaviour	19 (.21%)
Agitation	19 (.21%)
Cold Sweat	19 (.21%)
Drug Hypersensitivity	19 (.21%)
Haemorrhagic Stroke	19 (.21%)
Hypotension	19 (.21%)
Medication Error	19 (.21%)
No Therapeutic Response	19 (.21%)
Pneumocystis Jiroveci Pneumonia	19 (.21%)
Pneumonia	19 (.21%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Betamethasone, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Betamethasone is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Betamethasone

What are the most common Betamethasone adverse events reported to the FDA?

Epidermal And Dermal Conditions	744 (8.18%)
Neurological	359 (3.95%)
Infections - Pathogen Unspecified	316 (3.48%)
Respiratory	306 (3.37%)
Chemical Injury And Poisoning	208 (2.29%)
Therapeutic And Nontherapeutic Effe...	197 (2.17%)
Hematology Investigations	184 (2.02%)
Gastrointestinal Signs	170 (1.87%)
Allergic Conditions	151 (1.66%)
Cardiac And Vascular Investigations	133 (1.46%)
Administration Site Reactions	126 (1.39%)
	Show More
Bacterial Infectious	122 (1.34%)
Medication Errors	121 (1.33%)
Musculoskeletal And Connective Tiss...	109 (1.2%)
Injuries	107 (1.18%)
Movement Disorders	106 (1.17%)
Hepatic And Hepatobiliary	104 (1.14%)
Cardiac Arrhythmias	103 (1.13%)
Neonatal And Perinatal Conditions	97 (1.07%)
Body Temperature Conditions	91 (1%)
Lower Respiratory Tract Disorders	90 (.99%)
Central Nervous System Vascular	87 (.96%)
Gastrointestinal Motility And Defec...	86 (.95%)
Skin Appendage Conditions	86 (.95%)
Sleep Disorders	86 (.95%)
Muscle	84 (.92%)
Hepatobiliary	82 (.9%)
Glucose Metabolism Disorders	78 (.86%)
Obstetric And Gynecological Therape...	74 (.81%)
Procedural And Device Related Injur...	67 (.74%)
Fungal Infectious	66 (.73%)
White Blood Cell	66 (.73%)
Physical Examination Topics	63 (.69%)
Anxiety Disorders	61 (.67%)
Electrolyte And Fluid Balance Condi...	59 (.65%)
Headaches	59 (.65%)
Viral Infectious	59 (.65%)
Anemias Nonhemolytic And Marrow Dep...	58 (.64%)
Metabolic, Nutritional And Blood Ga...	58 (.64%)
Renal Disorders	58 (.64%)
Vision	55 (.6%)
Adrenal Gland	54 (.59%)
Ocular Infections, Irritations And ...	51 (.56%)
Coagulopathies And Bleeding Diathes...	50 (.55%)
Joint	50 (.55%)
Vascular	50 (.55%)
Decreased And Nonspecific Blood Pre...	46 (.51%)
Enzyme	46 (.51%)
Gastrointestinal Hemorrhages	43 (.47%)
Maternal Complications Of Labour An...	43 (.47%)
Angiedema And Urticaria	42 (.46%)
Mental Impairment	42 (.46%)
Vascular Hypertensive	42 (.46%)
Disturbances In Thinking	41 (.45%)
Pleural	41 (.45%)
Seizures	41 (.45%)
Deliria	39 (.43%)
Microbiology And Serology	39 (.43%)
Anterior Eye Structural Change, Dep...	38 (.42%)
Protein And Chemistry Analyses	38 (.42%)
Tissue	38 (.42%)
Abortions And Stillbirth	37 (.41%)
Cardiac Disorder Signs	37 (.41%)
Bone Disorders	36 (.4%)
Lifestyle Issues	35 (.38%)
Neonatal Respiratory	35 (.38%)
Upper Respiratory Tract Disorders	35 (.38%)
Coronary Artery	34 (.37%)
Eye	34 (.37%)
Therapeutic Procedures And Supporti...	34 (.37%)
Appetite And General Nutritional	33 (.36%)
Fetal Complications	33 (.36%)
Gastrointestinal Ulceration And Per...	33 (.36%)
Urinary Tract Signs	33 (.36%)
Skin Vascular Abnormalities	32 (.35%)
Bronchial Disorders	31 (.34%)
Pregnancy, Labour, Delivery And Pos...	31 (.34%)
Psychiatric And Behavioural Symptom...	31 (.34%)
Fatal Outcomes	30 (.33%)
Myocardial	30 (.33%)
Oral Soft Tissue Conditions	30 (.33%)
Gastrointestinal Tract Disorders Co...	29 (.32%)
Peritoneal And Retroperitoneal Cond...	29 (.32%)
Pulmonary Vascular	28 (.31%)
Exocrine Pancreas Conditions	27 (.3%)
Endocrine Investigations	26 (.29%)
Gastrointestinal Inflammatory Condi...	26 (.29%)
Protein And Amino Acid Metabolism	26 (.29%)
Renal And Urinary Tract Disorders C...	26 (.29%)
Lipid Metabolism	25 (.27%)
Miscellaneous And Site Unspecified ...	25 (.27%)
Cornification And Dystrophic Skin	24 (.26%)
Depressed Mood Disorders	24 (.26%)
Lipid Analyses	24 (.26%)
Placental, Amniotic And Cavity Diso...	24 (.26%)
Water, Electrolyte And Mineral	24 (.26%)
Heart Failures	23 (.25%)
Glaucoma And Ocular Hypertension	22 (.24%)
Inner Ear And Viiith Cranial Nerve	22 (.24%)
Personality Disorders	22 (.24%)
Cardiac And Vascular Disorders Cong...	21 (.23%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Betamethasone, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Betamethasone is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.